Stryker Corp (SYK)
328.27
+1.64
(+0.50%)
USD |
NYSE |
May 03, 13:28
Stryker Accounts Payable (Quarterly): 1.246B for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.246B |
December 31, 2023 | 1.517B |
September 30, 2023 | 1.296B |
June 30, 2023 | 1.326B |
March 31, 2023 | 1.366B |
December 31, 2022 | 1.413B |
September 30, 2022 | 1.213B |
June 30, 2022 | 1.16B |
March 31, 2022 | 1.084B |
December 31, 2021 | 1.129B |
September 30, 2021 | 934.00M |
June 30, 2021 | 864.00M |
March 31, 2021 | 767.00M |
December 31, 2020 | 810.00M |
September 30, 2020 | 647.00M |
June 30, 2020 | 635.00M |
March 31, 2020 | 736.00M |
December 31, 2019 | 675.00M |
September 30, 2019 | 659.00M |
June 30, 2019 | 616.00M |
March 31, 2019 | 619.00M |
December 31, 2018 | 646.00M |
September 30, 2018 | 563.00M |
June 30, 2018 | 561.00M |
March 31, 2018 | 529.00M |
Date | Value |
---|---|
December 31, 2017 | 487.00M |
September 30, 2017 | 458.00M |
June 30, 2017 | 427.00M |
March 31, 2017 | 456.00M |
December 31, 2016 | 437.00M |
September 30, 2016 | 420.00M |
June 30, 2016 | 425.00M |
March 31, 2016 | 394.00M |
December 31, 2015 | 410.00M |
September 30, 2015 | 340.00M |
June 30, 2015 | 342.00M |
March 31, 2015 | 333.00M |
December 31, 2014 | 329.00M |
September 30, 2014 | 335.00M |
June 30, 2014 | 337.00M |
March 31, 2014 | 350.00M |
December 31, 2013 | 314.00M |
September 30, 2013 | 278.00M |
June 30, 2013 | 277.00M |
March 31, 2013 | 297.00M |
December 31, 2012 | 288.00M |
September 30, 2012 | 270.00M |
June 30, 2012 | 295.00M |
March 31, 2012 | 311.00M |
December 31, 2011 | 345.00M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
616.00M
Minimum
Jun 2019
1.517B
Maximum
Dec 2023
1.005B
Average
1.009B
Median
Accounts Payable (Quarterly) Benchmarks
Boston Scientific Corp | 921.00M |
Haemonetics Corp | 56.84M |
Abbott Laboratories | 4.295B |
Edwards Lifesciences Corp | 212.30M |
Zimmer Biomet Holdings Inc | 410.60M |